M&A · Healthcare · Buyer's industry: Services-Commercial Physical & Biological Research
Charles River Laboratories International, Inc. to acquire Cognate Bioservices
Announced Feb 17, 2021 · Closed Mar 29, 2021 · Private target
Deal value$875M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- Charles River Laboratories International, Inc. (CRL)
- Target
- Cognate Bioservices
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Mar 29, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Gordon Dyal
- To the target
- Morgan Stanley
Classification
- Sector
- Healthcare
- Buyer's industry
- Services-Commercial Physical & Biological Research